26.11.2018 • News

Perstorp to Divest BioProducts

Perstorp to Divest BioProducts
Perstorp to Divest BioProducts

Swedish specialty chemicals producer Perstorp plans to sell its Perstorp BioProducts arm, a major producer of biodiesel and glycerine in Scandinavia, to a Swedish investor together with a member of the subsidiary’s management team.

Neither the identity of the new owners, financial terms of the transaction nor a closing date were revealed.

The sale includes the production site in Fredrikstad, Norway, but not the site at Stenungsund, Sweden, which will remain with Perstorp. For a limited time, the former parent will be a minority owner of the new company to be known as Adesso BioProducts. All 20 staff, based mostly in Fredrikstad, will be retained.

A tolling agreement, under which Perstorp will continue to produce biodiesel at Stenungsund for Adesso BioProducts, is part of the deal. If Adesso, longer term, decides to relocate production, Perstorp said it could repurpose the site to make other specialty chemical products.

Jan Secher, CEO of Perstorp, said the bioproducts manufacturer is one of the leading suppliers of biofuels in Scandinavia, and he sees “great potential” for the business under new ownership. For Perstorp, he said the sale is in line with its strategy to focus on high growth areas.

Adesso BioProducts’ CEO Lars Lind said that, due to the rapidly increasing focus on the decarbonization of the transportation sector, demand for biofuels and bio-based fuel components, the spinoff will see “continued strong growth” and the potential to expand. Along with developing the existing biofuel portfolio, he said management sees interesting opportunities in biocomponents suitable for advanced biofuels, carbon free aviation and bio-based chemicals.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.